The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Open accessAbstract
Studies on postmortem brains from Parkinson's patients reveal elevated iron in the substantia nigra (SN). Selective cell death in this brain region is associated with oxidative stress, which may be exacerbated by the presence of excess iron. Whether iron plays a causative role in cell death, however, is controversial. Here, we explore the effects of iron chelation via either transgenic expression of the iron binding protein ferritin or oral administration of the bioavailable metal chelator clioquinol (CQ) on susceptibility to the Parkinson's-inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP). Reduction in reactive iron by either genetic or pharmacological means was found to be well tolerated in animals in our studies and to result in protection against the toxin, suggesting that iron chelation may be an effective therapy for prevention and treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Genetic (with transgenic expression of ferritin) or pharmacological (by clioquinol) iron chelation resulted in the reduction of reactive iron protecting mice from the toxic effects derived from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.212”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [212]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two molecular chaperones of the heat-shock protein 70 class, ssc1 and ssc2, were shown to facilitate mitochondrial frataxin import and maturation in yeast (162, 312).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [162]
Experimental — accuracy not yet measuredIn the citing paper
“Nevertheless, iron chelators have demonstrated therapeutic benefits in Alzheimer's [1674,1710,1769-1771], Parkinson's [1037,1729,1772], cold-induced brain injury [1773,1774], coronary disease [714,797], renal diseases [1775], various kinds of infection [1763] and of course in iron overload diseases [1762,1767].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1772]
In the citing paper
“Chelated iron prevents ROS-induced damage to dopaminergic neurons (Kaur et al. 2003).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Kaur et al. 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,602
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995) · Nature · doi:10.1038/376037a0 · Cited by 3,979
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · cited 3×
“…CQ fed 7 days following chronic MPTP administration, *p 0.01, MPTP versus untreated wt; **p 0.01 CQ/MPTP versus MPTP-treated wt. in brain neurons (Harrison and Arosio, 1996; Connor et cal consequences (Curtis et al., 2001; Connor et al., 2001; Thompson et al., 2001).al., 1995; Han et al., 2000).”
InfluentialCherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 4×
“…animals in our studies and to result mulation in an Alzheimer’s disease (AD) transgenic in protection against the toxin, suggesting that iron mouse model via its actions as a metal chelator (Huang chelation may be an effective therapy for prevention et al., 1999; Bush, 2000; Cherny et al., 2001).”
InfluentialSelf-citationTransition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Oxidative stress and Alzheimer disease
Christen, Y. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111
Self-citation
Research works printed but not linked: 5
- Beard, 1993, Brain iron, Prog. Food Nutr. Sci., 17, 183
- Cheepsunthorn, 1998, Cellular distribution of ferritin subunits in postnatal rat brain, J. Comp. Neurol., 400, 73, 10.1002/(sici)1096-9861(19981012)400:1<73::aid-cne5>3.0.co;2-q · doi:10.1002/(sici)1096-9861(19981012)400:1<73::aid-cne5>3.0.co;2-q
- Clifford Rose, 1984, Clioquinol neurotoxicity, Acta Neurol. Scand. Suppl., 100, 137
- Marciani, 1991, Toxic effects of high-dose deferoxamine treatment in patients with iron overload, Haematologica, 76, 131
- Masters, C. (2002). Alzheimer's disease: modulation of the APP/beta-amyloid pathways toward rational therapeutic intervention. 8th International Conference on Alzheimer's Disease and Related Disorders, Stockholm, Sweden, July 20–25, 2002.
Cited by
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Self-citationReactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
The role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Self-citation
Metadata
- Authors
- Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., DiMonte, D., Volitaskis, I., Ellerby, L., Cherny, R. A., Bush, A. I., & Andersen, J. K.
- Affiliations
- Buck Institute for Research on Aging (US)
- University of Southern California (US)
- California Institute of Technology (US)
- Cornell University (US)
- Parkinson's Institute and Clinical Center (US)
- Mental Health Research Institute (AU)
- Harvard University (US)
- Corresponding author
- Andersen, Julie K
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 37
- Issue
- 6
- Pages
- 899-909
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2018974184
- Cited by
- 620
- References
- 96
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 16 · 2023: 20 · 2022: 22 · 2021: 20 · 2020: 24 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 28 · 2015: 34 · 2014: 31 · 2013: 28 · 2012: 34
- FWCI
- 29.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3791 d)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG012141, R01 AG12141, 2R01 AG 12686, R01 AG41264, R01AG012686)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- iron chelation, MPTP-induced neurotoxicity, Parkinson's disease, ferritin, clioquinol, substantia nigra, oxidative stress, iron overload, neuroprotection, dopaminergic neuron loss
- MeSH terms
- Animals, Dopamine, Ferritins, Homovanillic Acid, Humans, Immunohistochemistry, Clioquinol, Iron, Iron Chelating Agents, Mice, Transgenic, Parkinson Disease, Parkinson Disease, Secondary, Promoter Regions, Genetic, Substantia Nigra, Tyrosine 3-Monooxygenase, 3,4-Dihydroxyphenylacetic Acid, Blotting, Western, Genetic Therapy, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Gene Expression, Cell Death, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo. https://app.cochat.ai/papers/10.1016/s0896-6273(03)00126-0
- The paper
- Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., DiMonte, D., Volitaskis, I., Ellerby, L., Cherny, R. A., Bush, A. I., & Andersen, J. K. (2003). Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo. Neuron. https://doi.org/10.1016/s0896-6273(03)00126-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.